Narasimhan R, Roy Sitesh, Koralla Meghanadh, Thomas P K, Ilambarathi M, Balamurugan S, Harish M, Sabarinath R, Medikeri Gaurav, Bose Partha, Pattabhiraman V R, Rajasekar M K, Gayathri A R, Dhanasekar T, Nandagopal V, Gananathan G, Ravichandran S K, Shankar M N, Majumder Aniruddha, Shamim Shelley, Juvekar Meenesh, Singh Vijay K, Mohankumar T, Prasanna Kumar S, Jash Debraj, Bendre Salil, Neliyathodi Suhail, Unnithan Sunil Janardanan, Karadkhele Archana
Pulmonology Respiratory Medicine Specialist, Apollo Hospital, Chennai, Tamil Nadu, India.
Dr Roy Health Solutions Clinic, Mumbai, India.
Pulm Ther. 2025 Jun;11(2):129-155. doi: 10.1007/s41030-024-00273-z. Epub 2024 Oct 17.
Allergic rhinitis and asthma are commonly coexisting conditions, significantly impacting patient health and quality of life. Despite their interrelation, diagnosing allergic rhinitis in patients with asthma remains challenging, leading to underdiagnosis and suboptimal management. The expert consensus engaged a modified Delphi method involving 29 experts including pulmonologists, ear, nose, and throat surgeons, and allergologists. Through group discussions, consensus statements were developed regarding the epidemiology, diagnosis, and management of allergic rhinitis and asthma. Final consensus statements were formulated based on the experts' collective clinical judgment and experience. This expert consensus provides updated recommendations tailored to the Indian context, addressing the gaps in existing research and clinical practice. By promoting a systematic and evidence-based approach to diagnosis and management, this consensus aims to support clinicians in effectively identifying and treating allergic rhinitis in patients with asthma, thereby improving overall disease management and patient well-being.
过敏性鼻炎和哮喘是常见的共存疾病,对患者的健康和生活质量有重大影响。尽管它们相互关联,但在哮喘患者中诊断过敏性鼻炎仍然具有挑战性,导致诊断不足和管理不理想。专家共识采用了一种改良的德尔菲法,涉及29位专家,包括肺科医生、耳鼻喉科外科医生和过敏症专科医生。通过小组讨论,就过敏性鼻炎和哮喘的流行病学、诊断和管理制定了共识声明。最终的共识声明是基于专家的集体临床判断和经验制定的。这一专家共识提供了针对印度背景的最新建议,填补了现有研究和临床实践中的空白。通过推广系统的、基于证据的诊断和管理方法,这一共识旨在支持临床医生有效识别和治疗哮喘患者的过敏性鼻炎,从而改善整体疾病管理和患者健康状况。